[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"mixed-ulcer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:mixed-ulcer":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":4,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100518528","fetal-cell-receptors-repertoire-100518528",false,"NCT06031714","Fetal Cell Receptors Repertoire","\"Study of CCR Receptor Overexpression in Fetal Microchimeric Cells: Proof of Concept Before a Potential Clinical Trial\"","MoreCCR","Inclusion Criteria:\n\nCommon criteria :\n\n* Adult women,\n* Post-partum: having been pregnant for any length of time,\n* Having signed a free and informed consent form,\n* Primiparous or multiparous,\n* Affiliated to a health insurance\n\nPatients :\n\n\\- Patients with a venous, diabetic or sickle cell ulcer, or mixed ulcer\n\nControl group patients :\n\n* Volunteers,\n* Age-matched,\n* Without skin ulcers.\n\nThere are no specific criteria for children.\n\nExclusion Criteria:\n\n* Minors (for patients)\n* Under court protection, curatorship, guardianship (for patients)\n* Immunocompromised patients for any reason whatsoever\n* Refusal of consent\n* Refusal of blood and\u002For saliva samples for themselves or a member of their family",true,"ALL",{"count":20,"type":21},160,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this study is to describe the transcriptomic profile of foetal cells in post-partum and more specifically to determine which chemokine receptors are overexpressed in foetal cells in post-partum women with wounds To do so, the investigators will isolate foetal cells from the peripheral blood of healthy controls post partum women as well as from post partum women with skin ulcers and then perform RNA sequencing.",[27,28,29,30,31],"Venous Ulcer","Sickle Cell Ulcer","Diabetic Ulcer","Post-partum Women","Mixed Ulcer",[33,34,35],"Microchimerism","Foetal stem cells","Receptors","RECRUITING","2025-09-05",{"date":39,"type":40},"2025-09-12","ACTUAL",{"date":42,"type":40},"2024-02-06",{"date":44,"type":21},"2027-02-01",{"name":46,"class":47},"Assistance Publique - Hôpitaux de Paris","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":18,"minAge":55,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":56,"phases":4,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":64,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":68,"locationsCount":48},"100572188","dermacyte-liquid-for-treatment-of-cutaneous-ulcers-and-wounds-100572188","NCT06730022","Dermacyte® Liquid for Treatment of Cutaneous Ulcers and Wounds","Inclusion Criteria:\n\n* Must be 18 years of age or older\n* Must have a cutaneous ulcer or wound refractory to initial treatment or does not have an adequate treatment alternative, as determined by the Investigator\n\nExclusion Criteria:\n\n* Must not be pregnant or lactating\n* Must not have known malignancies\n* Must not be less than 18 years of age","18 Years","EXPANDED_ACCESS","The objective of this study is to make Dermacyte Liquid available on an expanded access basis to treat cutaneous ulcers and wounds refractory to initial treatment or that do not have adequate alternative treatments. Minimal data will be collected to evaluate the efficacy and safety of Dermacyte Liquid.",[59,29,60,61,62,31,63],"Cutaneous Ulcer","Surgical Wound Dehiscence","Burns - Multiple","Pressure Ulcers","Ischemic Ulcer","AVAILABLE","2025-02-21",{"date":67,"type":40},"2025-02-25",{"name":69,"class":70},"Merakris Therapeutics","INDUSTRY"]